|
Volumn 33, Issue 2, 2001, Pages 357-362
|
Radical cystectomy versus alternative treatments for muscle-confined bladder cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
COBALT 60;
IMMUNOMODULATING AGENT;
METHOTREXATE;
VINBLASTINE;
ANTINEOPLASTIC AGENT;
ADULT;
AGED;
ARTICLE;
BLADDER CANCER;
BLADDER MUSCLE;
CANCER ADJUVANT THERAPY;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
COMPARATIVE STUDY;
CONTROLLED STUDY;
CYSTECTOMY;
DISEASE COURSE;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL DISEASE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
POSTOPERATIVE COMPLICATION;
QUALITY OF LIFE;
SALVAGE THERAPY;
TRANSURETHRAL RESECTION;
URETHRA DISEASE;
VASCULAR DISEASE;
BLADDER TUMOR;
MIDDLE AGED;
MORTALITY;
RADIATION DOSE;
RETROSPECTIVE STUDY;
SURVIVAL;
TIME;
TRANSITIONAL CELL CARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLADDER NEOPLASMS;
CARCINOMA, TRANSITIONAL CELL;
CYSTECTOMY;
FEMALE;
FOLLOW-UP STUDIES;
HUMAN;
MALE;
MIDDLE AGE;
RADIOTHERAPY DOSAGE;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TIME FACTORS;
HUMANS;
MIDDLE AGED;
URINARY BLADDER NEOPLASMS;
|
EID: 0035527462
PISSN: 03011623
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1015261628978 Document Type: Article |
Times cited : (6)
|
References (24)
|